Qiagen completes FDA, EUDAMED listings for QIAsymphony Connect platform
QGEN•FDA and EUDAMED listings completed
- Qiagen completed FDA listing in the U.S. for QIAsymphony Connect, its IVD-compliant automated clinical nucleic acid extraction platform.
- Europe EUDAMED listing was also completed, clearing key regulatory steps for broader commercial rollout.
